semaglutide med may lower risk of serious complications in high-risk diabetes - Semaglutide: A Game-Changer in Weight

This article explains the clinical considerations, monitoring protocols, and how understanding your genetic predispositions may support more personalized treatment conv

Find out the common signs of an allergic reaction and next steps if you are allergic.

Results Of the 138,397 patients, 57% received neither SGLT2-I nor GLP-1RA, 17% received both, 20% received SGLT2-I only, and 6% received GLP-1RA only

While their metabolic benefits are well-established, their potential effects on vestibular function remain ...

While fasting GLP-1 remained largely unchanged, postprandial concentrations rose markedly at 6 months (total AUC increase in RYGB: ~330%, OAGB: ~259%